Wealth Awesome
TSX closed
Loading markets…
Interactive Brokers: IBKR clients beat the S&P 500 in 2025 — 19.20% average client return vs 17.9% for the index, net of commissions and charges.
Stocks/TSX/APTX

Apotex Health Corp (APTX : TSX)

$41.70CAD+0.53 (1.29%)Close of 2026-11-19

Common Stock

Follow APTX

APTX

Apotex Health Corp

Source:WealthAwesomeWealthAwesome
↑ $11.16 (36.54%)
30 day period
$30.54$36.12$41.70Oct 8Oct 30Nov 19

Performance

1 Day

+1.29%

1 Week

+8.42%

1 Month

+28.31%

YTD

+54.70%

The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.

Key Statistics

Market Cap

$9.15B

52W High

$41.23

52W Low

$26.01

P/E Ratio

-

50 Day MA

$33.45

200 Day MA

$33.86

Beta

-

Dividend Yield

0.15%

WA Score

How APTX stacks up against 931 Canadian stocks

out of 99

  • Value49

    Not profitable over the last 12 months.

  • Quality
  • Momentum91

    54.7% this year, above its 200-day average, 100% of the way up its 52-week range.

  • Analysts
  • Insiders

Each factor is a percentile against Canadian common stocks worth $50M or more on the TSX and TSX Venture (90 = better than 90% of them). Built from exchange prices, company financials, analyst targets and SEDI insider filings. A data summary, not advice. How it works · Top-scoring stocks

Performance history

APTX returns since 2026

Apotex Health Corp has traded since Jun 2026 in our data. Its deepest fall was −22.9% (Jul 2026 to Oct 2026).

1 year / yr

—

3 years / yr

—

5 years / yr

—

10 years / yr

—

Calendar-year returns

  • 2026*+54.7%

* Partial year (first year of data, or year to date).

$10,000 invested in APTX

  • 2026 (start of our data)$15,470
All-time high in our data
$42 on Nov 19, 2026 · at the high

Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Jun 2026 to Nov 2026. Past returns do not predict future ones.

Earnings

APTX earnings history

Apotex Health Corp beat the EPS estimate in 2 of its last 2 reported quarters.

0.00000.35000.7000 26-0626-09 Estimate Actual (≥0) Actual (<0) Wealth Awesome
Quarter endingReportedEPSEstimateSurprise
Sep 30, 2026Nov 12, 2026$0.57$0.44+29.2%
Jun 30, 2026Aug 12, 2026$0.70$0.46+52.2%

EPS as reported vs consensus estimate. TSX earnings calendar →

Awesome Portfolio™

Looking past APTX? Our 10 best Canadian stocks, in one list.

14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.

See the portfolio →

Apotex Health Corp insider transactions

Open-market and private equity trades (last 12 months volume). Derivatives and opening balances excluded.

Shares soldShares bought0–3 monthsSold by companies: 24.5MSold by individuals: 532k25.0M3–6 months6–9 months9–12 months
Sold · individuals Sold · companies Bought · individuals Bought · companies

Recent transactions

DateSideNameSharesPrice
Sep 18, 26Sell
Oberman, Allan Grant
Individual · CA$18.1m
532,062CA$34.00
Sep 18, 26Sell
SK Artemis Holdings II, LLC
Company · CA$654.6m
19,252,009CA$34.00
Sep 18, 26Sell
API Investment LP
Company · CA$177.3m
5,215,929CA$34.00

Full APTX insider trading page →

Technical Indicators

Price vs 50-Day SMA

↑Above 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/19/2026$41.55$42.31$41.47$41.70$41.70745,457
11/18/2026$39.88$41.23$39.72$41.17$41.17775,851
11/17/2026$40.14$40.74$39.60$39.93$39.93501,896
11/16/2026$39.61$40.34$38.95$40.28$40.28525,326
11/13/2026$38.50$40.10$38.50$39.44$39.44504,077
11/12/2026$37.05$39.05$36.25$38.46$38.461,207,447
11/11/2026$35.62$36.23$35.34$36.00$36.00283,970
11/10/2026$35.50$35.96$35.42$35.54$35.54245,817
11/9/2026$34.80$35.91$34.49$35.90$35.90572,933
11/6/2026$33.88$34.58$33.78$34.48$34.48410,081

Analyst Price Targets

Based on analyst covering APTX · as of Nov 19, 2026

📈

Wall Street analysts forecast APTX stock price to rise 5.7% over the next 12 months.

Consensus

Moderately Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$44.06

+5.7% Upside

Previously C$41.37 on Sep 23, 2026

Current Price

C$41.70

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on APTX's historical volatility

HistoricalForecast68%95%
C$29.62C$39.38C$49.13C$58.88C$68.63C$78.38TodayJul 14Sep 17Nov 19Jan 1Feb 14Mar 29

30-Day Vol

35.4%

Annualized

90-Day Vol

42.0%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$49.85

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$44.26C$39.17 – C$50.00
60 trading daysC$46.97C$39.52 – C$55.82
90 trading daysC$49.85C$40.35 – C$61.59

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Apotex Health Corp

Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. Apotex Health Corp. has a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent, Inc. and changed its name to Apotex Health Corp. in May 2026. The company was founded in 1974 and is headquartered in Toronto, Canada. Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC.

Financials

Revenue (TTM)
$3.21B
EBITDA
$767.34M
Profit Margin
-0.29%
ROE (TTM)
0.00%
EPS (Diluted)
-0.03
Book Value
1.88

Recent Dividends

$0.0600CAD

Ex: Sep 15, 2026

Pay: Sep 30

None

Free newsletter

The Saturday TSX Wrap

Saturday morning

The week on the TSX, in five minutes

  • The biggest gainers and losers, and why they moved
  • Sector and momentum moves at a glance
  • The Canadian market stories you missed

Free. One email a week. Unsubscribe any time.

Common Questions About APTX

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
GRCGold Springs Resource Corp$0.06+37.50%
MDNAMedicenna Therapeutics Corp$0.22+22.22%
DRXADF Group Inc.$20.78+20.88%
DNDDye & Durham Ltd$0.98+13.95%
TTelus Corp$15.50+13.72%
BUBurcon NutraScience Corporation$0.85+13.33%
DII-BDorel Industries Inc$1.35+8.87%
PYRPyroGenesis Canada Inc.$0.19+8.57%

Free with a Wealth Awesome account

Keep analysing APTX, free

  • Every WA Score, ranking and table
  • Insider track records and SEDI filings
  • Earnings history and analyst targets for every stock

Email only, no password, no card. Already a member? Use the same button to sign in.